Industry News
Analytica achieves its first positive cash flow
Analytica has posted its first positive operating cash flow on the back of its takeover by listed medical diagnostics group Psiron last year. [ + ]
Gene responsible for rare body-fat disorder identified
An international team of researchers led by scientists at UT Southwestern Medical Center at Dallas have identified the gene that causes a rare body-fat disorder, a discovery that may ultimately expand the understanding of obesity-related illnesses.
[ + ]Prima technology showing positive results
Prima Biomed's (ASX: PRR) vaccine platform technology has taken another step towards success by triggering a strong immune response in large animals, the company reported today. [ + ]
Wilmut disappointed, others happy with cloning progress
Recent media interviews with Dr Ian Wilmut, the scientist responsible for cloning Dolly the sheep, have suggested that all clones are genetically and physically defective. [ + ]
McGauran promises action on killer jellyfish research
Science Minister Peter McGauran has pledged his support to a call for funding to research the tiny irukandji jellyfish, which has claimed two lives off the Queensland coast this year. [ + ]
New bio-investor launches IPO
Australia's latest biotech share offering opens this week when device and diagnostics investment company Premier Bionics launches its IPO. [ + ]
ES Cell scores US grant, license deal
Melbourne's ES Cell International has scored a double coup in the United States with the awarding of a National Institutes of Health infrastructure grant and the signing of a research licensing deal. [ + ]
Compumedics buys US company, eyes Nasdaq
Developer of sleep disorders devices Compumedics has completed its first acquisition with the $US4 million purchase of Texas-based neurological instruments business Neuroscan. [ + ]
Universities face review
Non-productive research, inflated course offerings, and inefficient bureaucrats in the higher education sector are some of the issues to be addressed in the first of a series of reviews of higher education by the Federal government. [ + ]
Forum series threatened by lack of speakers
The success of a Victorian government gene technology and biotech forum series was under threat because of a dearth of willing expert speakers, according to the Department of Human Services (DHS). [ + ]
Confirmant set to release Protein Atlas
US company Confirmant is racing to finish up the first commercial version of its Protein Atlas for June, but life science researchers and industry analysts say a warm reception is far from assured. [ + ]
Peplin researches pancreas
Peplin Biotech has broadened its research pipeline for anti-cancer drugs that target diseases of the pancreas. [ + ]
Nanospace breakthrough in membrane technology
A team of Australian and US scientists has announced a world advance in the use of membrane technology to filter and separate various gases and vapours.
[ + ]BresaGen wins NIH deal
A second Australian company has won the right to provide embryonic stem cell lines to the National Institutes of Health (NIH) in the United States. [ + ]
UNSW calls in heavyweights over allegations
Ongoing investigations into the alleged misconduct of a University of New South Wales scientist, Prof Bruce Hall, are to be directed by a selection panel comprised of eminent scientist Sir Gustav Nossal and UNSW chancellor Dr John Yu and vice-chancellor Prof John Niland. [ + ]